A review of studies on vitamin D in schizophrenia and depression found insufficient evidence to inform advice for clinicians. On the basis of the review, I suggest advice for researchers, including better controlling for confounders in observational studies, testing the reverse causality hypothesis, studying vitamin D as a treatment or prevention specifically in patients with more pigmented skin, and prospective community trials of vitamin D supplementation combined with lifestyle advice. [ABSTRACT FROM AUTHOR]
Copyright of BJPsych Advances is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
